Galway medical devices firm storms Europe

6 Jul 2009

Share on FacebookTweet about this on TwitterShare on LinkedInShare on Google+Pin on PinterestShare on RedditEmail this to someone

Share on FacebookTweet about this on TwitterShare on LinkedInShare on Google+Pin on PinterestShare on RedditEmail this to someone

Young Galway medical device developer Crospon has shipped its first product to the European market after its EndoFLIP system went into commercial production.

Crospon’s flagship gastroenterology product, EndoFLIP has been shipped to the European market.

Following the announcement of a worldwide distribution deal in May with Dutch company, Medical Measurement Systems, Crospon has completed its start-up activities for EndoFLIP and has now gone into commercial production.

Crospon develops leading-edge minimally invasive medical devices for monitoring, diagnosis and therapy in the gastroenterology area.

“The shipment marks a real milestone both for Crospon and EndoFLIP,” says John O’Dea, CEO, Crospon.

“We as a team at Crospon have been working towards this target for the past two years. I would like to take this opportunity to thank all of the staff at Crospon who have each played an integral part in bringing the company to this point.

“We look forward taking to the next steps in extending the application of the EndoFLIP platform technology into the Bariatric Surgery marketplace in the coming year,” O’Dea adds.

The EndoFLIP tool which is pending FDA approval was designed by Crospon to provide a more physiologically relevant diagnostic test for gastroesophageal reflux disease (GERD). Chronic GERD is a prevalent disorder reaching epidemic proportions worldwide that manifests itself as severe heartburn caused by stomach acid refluxing up into the oesophagus.

Crospon’s development of the EndoFLIP system was recently recognised with the 2009 European Gastroenterology Technology Implementation of the Year Award, by Frost & Sullivan.

In January, Crospon announced that its EndoFLIP system had received CE Mark certification from the NSAI (National Standards Authority of Ireland), the Irish notified body, in accordance with the European Medical Device Directive.

The company also appointed a vice-president of sales for the Americas, Larry Fulton, to head its US operation in California.

By John Kennedy

Pictured: John O’Dea, CEO, Crospon

Editor John Kennedy is an award-winning technology journalist.

editorial@siliconrepublic.com